This product is not available in the U.S.

Innovations for Treating Life-Threatening Bloodstream Infections

The Seraph® 100 Microbind® Affinity Blood Filter (Seraph 100) is a single use, extracorporeal blood filter used to reduce the level of pathogens in the bloodstream.
bg-hero
revolutionary-treatment-1

Revolutionary Treatment to Combat Bloodstream Infections

Seraph 100 was the first device with an indication to specifically reduce pathogens in the bloodstream in adjunction to antibiotic therapy. A long-awaited addition to conventional approaches to treat drug-resistant and drug-susceptible pathogens.

antibiotic-stewardship

Pathogen Reduction

The binding properties of the Seraph 100 reduce pathogens from the bloodstream regardless of anti-infective medication resistance/super-resistance.

Our Technology

As blood flows through the Seraph filter, it passes over microbeads coated with molecular heparin receptor sites that mimic the heparan sulfate receptors on human cells that pathogens attack when invading the body. These harmful pathogens bind to the Seraph beads and are removed from the bloodstream.

About Exthera Medical

ExThera Medical develops extracorporeal blood filtration devices, including the Seraph® 100 Microbind® Affinity Blood Filter for removing harmful substances from the bloodstream of patients.

ExThera Medical’s extracorporeal products are in development for patients suffering from severe infections. Company headquarters is located in Martinez, California.

MM-00059 Rev B

ExThera Medical Corporation | 757 Arnold Drive | Suite B | Martinez, CA 94550

Tel:  +1.925.839.2060 | Fax: +1.925.839.2075

© 2025 ExThera Medical

USA (English) | Contact Us | Privacy Policy | Consent Preference

Seraph 100 is not currently available in the EU.
MM-00060 Rev C